Patient Inclusion Criteria
All patients referred on HNC two-week-wait pathway between April 2020 and November 2020 were identified. All patients received an initial telephone consultation and were followed up for six months. Patients who received a new cancer diagnosis presenting with head and neck symptoms at any point in this time were included in the study. Cases with cancers that were incidentally diagnosed that were unrelated to the index referral were excluded.